The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Meningitis Vaccine-Global Market Insights and Sales Trends 2025
Synopsis
The global Meningitis Vaccine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Meningitis Vaccine in various end use industries. The expanding demands from the Medical Care and Hospital, are propelling Meningitis Vaccine market. Meningitis A+C, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Meningitis ACWY135 segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Meningitis Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Meningitis Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Meningitis Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Meningitis Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Meningitis Vaccine covered in this report include GlaxoSmithKline, Baxter International, Sanofi Pasteur, Merck, Novartis, Pfizer, Hualan, Zhejiang Tianyuan and Beijing Tiantan Biological, etc.
The global Meningitis Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
Baxter International
Sanofi Pasteur
Merck
Novartis
Pfizer
Hualan
Zhejiang Tianyuan
Beijing Tiantan Biological
Global Meningitis Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Meningitis Vaccine market, Segment by Type:
Meningitis A+C
Meningitis ACWY135
Meningitis B
Global Meningitis Vaccine market, by Application
Medical Care
Hospital
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Meningitis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Meningitis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Meningitis Vaccine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Meningitis Vaccine in various end use industries. The expanding demands from the Medical Care and Hospital, are propelling Meningitis Vaccine market. Meningitis A+C, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Meningitis ACWY135 segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Meningitis Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Meningitis Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Meningitis Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Meningitis Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Meningitis Vaccine covered in this report include GlaxoSmithKline, Baxter International, Sanofi Pasteur, Merck, Novartis, Pfizer, Hualan, Zhejiang Tianyuan and Beijing Tiantan Biological, etc.
The global Meningitis Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
Baxter International
Sanofi Pasteur
Merck
Novartis
Pfizer
Hualan
Zhejiang Tianyuan
Beijing Tiantan Biological
Global Meningitis Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Meningitis Vaccine market, Segment by Type:
Meningitis A+C
Meningitis ACWY135
Meningitis B
Global Meningitis Vaccine market, by Application
Medical Care
Hospital
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Meningitis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Meningitis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Meningitis Vaccine Market Overview
1.1 Meningitis Vaccine Product Overview
1.2 Meningitis Vaccine Market Segment by Type
1.2.1 Meningitis A+C
1.2.2 Meningitis ACWY135
1.2.3 Meningitis B
1.3 Global Meningitis Vaccine Market Size by Type
1.3.1 Global Meningitis Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Meningitis Vaccine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Meningitis Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Meningitis Vaccine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Meningitis Vaccine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Meningitis Vaccine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Meningitis Vaccine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Meningitis Vaccine Sales Breakdown by Type (2018-2023)
2 Global Meningitis Vaccine Market Competition by Company
2.1 Global Top Players by Meningitis Vaccine Sales (2018-2023)
2.2 Global Top Players by Meningitis Vaccine Revenue (2018-2023)
2.3 Global Top Players by Meningitis Vaccine Price (2018-2023)
2.4 Global Top Manufacturers Meningitis Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Meningitis Vaccine Market Competitive Situation and Trends
2.5.1 Meningitis Vaccine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Meningitis Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Meningitis Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Meningitis Vaccine Market
2.8 Key Manufacturers Meningitis Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Meningitis Vaccine Status and Outlook by Region
3.1 Global Meningitis Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Meningitis Vaccine Historic Market Size by Region
3.2.1 Global Meningitis Vaccine Sales in Volume by Region (2018-2023)
3.2.2 Global Meningitis Vaccine Sales in Value by Region (2018-2023)
3.2.3 Global Meningitis Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Meningitis Vaccine Forecasted Market Size by Region
3.3.1 Global Meningitis Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Meningitis Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Meningitis Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Meningitis Vaccine by Application
4.1 Meningitis Vaccine Market Segment by Application
4.1.1 Medical Care
4.1.2 Hospital
4.2 Global Meningitis Vaccine Market Size by Application
4.2.1 Global Meningitis Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Meningitis Vaccine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Meningitis Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Meningitis Vaccine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Meningitis Vaccine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Meningitis Vaccine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Meningitis Vaccine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Meningitis Vaccine Sales Breakdown by Application (2018-2023)
5 North America Meningitis Vaccine by Country
5.1 North America Meningitis Vaccine Historic Market Size by Country
5.1.1 North America Meningitis Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Meningitis Vaccine Sales in Volume by Country (2018-2023)
5.1.3 North America Meningitis Vaccine Sales in Value by Country (2018-2023)
5.2 North America Meningitis Vaccine Forecasted Market Size by Country
5.2.1 North America Meningitis Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Meningitis Vaccine Sales in Value by Country (2024-2029)
6 Europe Meningitis Vaccine by Country
6.1 Europe Meningitis Vaccine Historic Market Size by Country
6.1.1 Europe Meningitis Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Meningitis Vaccine Sales in Volume by Country (2018-2023)
6.1.3 Europe Meningitis Vaccine Sales in Value by Country (2018-2023)
6.2 Europe Meningitis Vaccine Forecasted Market Size by Country
6.2.1 Europe Meningitis Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Meningitis Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Meningitis Vaccine by Region
7.1 Asia-Pacific Meningitis Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Meningitis Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Meningitis Vaccine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Meningitis Vaccine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Meningitis Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Meningitis Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Meningitis Vaccine Sales in Value by Region (2024-2029)
8 Latin America Meningitis Vaccine by Country
8.1 Latin America Meningitis Vaccine Historic Market Size by Country
8.1.1 Latin America Meningitis Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Meningitis Vaccine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Meningitis Vaccine Sales in Value by Country (2018-2023)
8.2 Latin America Meningitis Vaccine Forecasted Market Size by Country
8.2.1 Latin America Meningitis Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Meningitis Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Meningitis Vaccine by Country
9.1 Middle East and Africa Meningitis Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Meningitis Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Meningitis Vaccine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Meningitis Vaccine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Meningitis Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Meningitis Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Meningitis Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Company Information
10.1.2 GlaxoSmithKline Introduction and Business Overview
10.1.3 GlaxoSmithKline Meningitis Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GlaxoSmithKline Meningitis Vaccine Products Offered
10.1.5 GlaxoSmithKline Recent Development
10.2 Baxter International
10.2.1 Baxter International Company Information
10.2.2 Baxter International Introduction and Business Overview
10.2.3 Baxter International Meningitis Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Baxter International Meningitis Vaccine Products Offered
10.2.5 Baxter International Recent Development
10.3 Sanofi Pasteur
10.3.1 Sanofi Pasteur Company Information
10.3.2 Sanofi Pasteur Introduction and Business Overview
10.3.3 Sanofi Pasteur Meningitis Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Sanofi Pasteur Meningitis Vaccine Products Offered
10.3.5 Sanofi Pasteur Recent Development
10.4 Merck
10.4.1 Merck Company Information
10.4.2 Merck Introduction and Business Overview
10.4.3 Merck Meningitis Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Merck Meningitis Vaccine Products Offered
10.4.5 Merck Recent Development
10.5 Novartis
10.5.1 Novartis Company Information
10.5.2 Novartis Introduction and Business Overview
10.5.3 Novartis Meningitis Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Novartis Meningitis Vaccine Products Offered
10.5.5 Novartis Recent Development
10.6 Pfizer
10.6.1 Pfizer Company Information
10.6.2 Pfizer Introduction and Business Overview
10.6.3 Pfizer Meningitis Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Pfizer Meningitis Vaccine Products Offered
10.6.5 Pfizer Recent Development
10.7 Hualan
10.7.1 Hualan Company Information
10.7.2 Hualan Introduction and Business Overview
10.7.3 Hualan Meningitis Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Hualan Meningitis Vaccine Products Offered
10.7.5 Hualan Recent Development
10.8 Zhejiang Tianyuan
10.8.1 Zhejiang Tianyuan Company Information
10.8.2 Zhejiang Tianyuan Introduction and Business Overview
10.8.3 Zhejiang Tianyuan Meningitis Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Zhejiang Tianyuan Meningitis Vaccine Products Offered
10.8.5 Zhejiang Tianyuan Recent Development
10.9 Beijing Tiantan Biological
10.9.1 Beijing Tiantan Biological Company Information
10.9.2 Beijing Tiantan Biological Introduction and Business Overview
10.9.3 Beijing Tiantan Biological Meningitis Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Beijing Tiantan Biological Meningitis Vaccine Products Offered
10.9.5 Beijing Tiantan Biological Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Meningitis Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Meningitis Vaccine Industrial Chain Analysis
11.4 Meningitis Vaccine Market Dynamics
11.4.1 Meningitis Vaccine Industry Trends
11.4.2 Meningitis Vaccine Market Drivers
11.4.3 Meningitis Vaccine Market Challenges
11.4.4 Meningitis Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Meningitis Vaccine Distributors
12.3 Meningitis Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
